Jerusalem, Israel

Elimelech Rochlin

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Bio-Lab, Inc., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elimelech Rochlin. Retrieved from https://idiyas.com/inventor/elimelech-rochlin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elimelech Rochlin: Innovator in Sphingolipid Research

Introduction

Elimelech Rochlin is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of sphingolipid research, holding 2 patents that focus on novel chemical compounds and their applications in pharmaceuticals.

Latest Patents

Rochlin's latest patents include innovative sphingolipid-polyalkylamines conjugates. This invention concerns the preparation of these conjugates and their use in pharmaceutical compositions. A preferred embodiment of this invention is the ceramide-spermine conjugate, specifically N-palmitoyl D-erythro sphingosyl-1-carbamoyl spermine. Additionally, he has developed methods for synthesizing sphingomyelin and its analogs, detailing novel cyclic and acyclic oxazaphospholanes.

Career Highlights

Throughout his career, Elimelech Rochlin has worked with prominent companies such as Bio-Lab, Inc. and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has significantly advanced the understanding and application of sphingolipids in various fields.

Collaborations

Rochlin has collaborated with esteemed colleagues, including Yechezkel Barenholz and Dmitri Simberg. These partnerships have further enriched his research and contributions to the scientific community.

Conclusion

Elimelech Rochlin's innovative work in sphingolipid research exemplifies the impact of dedicated inventors in advancing pharmaceutical science. His patents and collaborations continue to influence the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…